Assertio Therapeutics Inc (ASRT)

Assertio Therapeutics (ASRT) Financial Statements


Assertio Therapeutics Financial Overview

Assertio Therapeutics's market cap is currently ―. The company's EPS TTM is $1.754; its P/E ratio is 3.65; Assertio Therapeutics is scheduled to report earnings on May 4, 2023, and the estimated EPS forecast is $0.17. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 50.35M$ 34.21M$ 35.13M$ 36.54M$ 33.33M
Gross Profit$ 44.34M$ 30.20M$ 30.60M$ 32.34M$ 28.43M
EBIT$ 9.78M$ 6.36M$ 10.70M$ 12.10M$ 7.48M
EBITDA$ 18.15M$ 14.48M$ 18.91M$ 20.80M$ 14.86M
Net Income Common Stockholders$ 88.55M$ 4.17M$ 7.83M$ 9.06M$ 4.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 64.94M$ 64.83M$ 52.26M$ 61.39M$ 36.81M
Total Assets$ 413.91M$ 323.34M$ 321.98M$ 339.13M$ 326.55M
Total Debt$ 66.87M$ 68.16M$ 61.16M$ 73.52M$ 73.49M
Net Debt$ 1.93M$ 3.33M$ 8.90M$ 12.13M$ 36.68M
Total Liabilities$ 188.19M$ 188.43M$ 193.61M$ 227.27M$ 224.13M
Stockholders Equity$ 225.72M$ 134.91M$ 128.37M$ 111.86M$ 102.41M
Cash Flow-
Free Cash Flow$ 26.42M$ 10.04M$ 14.43M$ 27.43M$ 4.08M
Operating Cash Flow$ 26.70M$ 10.04M$ 14.43M$ 27.43M$ 4.13M
Investing Cash Flow$ -25.78M$ -371.00K$ -16.11M$ -404.00K$ -18.52M
Financing Cash Flow$ -798.00K$ 2.89M$ -7.44M$ -2.44M$ -7.52M
Currency in USD

Assertio Therapeutics Earnings and Revenue History

Assertio Therapeutics Debt to Assets

Assertio Therapeutics Cash Flow

Assertio Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis